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On the use of Parylene C polymer 
as substrate for peripheral nerve 
electrodes
Natàlia de la Oliva1, Matthias Mueller2, Thomas Stieglitz  2, Xavier Navarro  1 &  
Jaume del Valle1,3
Parylene C is a highly flexible polymer used in several biomedical implants. Since previous studies have 
reported valuable biocompatible and manufacturing characteristics for brain and intraneural implants, 
we tested its suitability as a substrate for peripheral nerve electrodes. We evaluated 1-year-aged in 
vitro samples, where no chemical differences were observed and only a slight deviation on Young’s 
modulus was found. The foreign body reaction (FBR) to longitudinal Parylene C devices implanted 
in the rat sciatic nerve for 8 months was characterized. After 2 weeks, a capsule was formed around 
the device, which continued increasing up to 16 and 32 weeks. Histological analyses revealed two 
cell types implicated in the FBR: macrophages, in contact with the device, and fibroblasts, localized 
in the outermost zone after 8 weeks. Molecular analysis of implanted nerves comparing Parylene C 
and polyimide devices revealed a peak of inflammatory cytokines after 1 day of implant, returning to 
low levels thereafter. Only an increase of CCL2 and CCL3 was found at chronic time-points for both 
materials. Although no molecular differences in the FBR to both polymers were found, the thick tissue 
capsule formed around Parylene C puts some concern on its use as a scaffold for intraneural electrodes.
Neural interfaces are the base of advanced neuroprostheses as they are responsible to bidirectionally communi-
cate the nervous system with the mechanical prosthesis1,2. Neural interfaces should be able to record high-quality 
nerve signals to drive the prosthetic limb and to stimulate specific groups of axons within a nerve to evoke sen-
sory feedback to control the prosthesis over long periods of time accurately. In order to achieve this communi-
cation, different types of electrodes for the use in peripheral nerves have been developed3, being the intraneural 
electrodes the most promising option to obtain a high selectivity of stimulation and recording with an acceptable 
invasiveness4–6.
However, after the implantation of any device in the body, an immune-mediated response – known as foreign 
body reaction (FBR) – occurs. The FBR is an immune-mediated response to any device implanted in the body. It 
is characterized by a first inflammatory phase followed by a tissue remodeling phase, which results in the encap-
sulation of the implant with immune cells and fibrotic tissue7,8 and it may finally lead to the failure of the device 
due to the lack of interaction with the tissue9,10.
Intraneural interfaces should have good biocompatibility and stability to remain inside the nerves for months 
or years, and the substrate material on which the electrode is made has an essential role in this maintenance11. It 
has to be biocompatible and biostable, avoiding the release of degrading particles that will induce an exacerbated 
inflammatory reaction. Another recognized problem is the mismatch of compliance between neural tissue and 
the implant material; indeed, reducing biomaterial stiffness can reduce the activation of immune cells leading to a 
less severe FBR12. Regarding the advances in biocompatible materials, several polymers have emerged as feasible 
options as substrates of flexible neural electrodes, such as polyimide and Parylene C, which also offer excellent 
insulation properties between adjacent metal tracks13.
Parylene C is a highly flexible polymer that has been used in many biomedical applications, e.g., as a coating 
for implants and electronic circuits10,14 as well as a substrate material for neural interfaces15,16, retinal implants17 
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and brain implants13,18 due to its good biocompatibility and biostability18–21. Moreover, unlike polyimide and 
other polymers used, Parylene C allows for thinner layers that could improve the implantation procedure and 
reduce the damage to the nerves16,22. Thus, Parylene C would be a good candidate to act as a scaffold of flexible 
interfaces for the peripheral nerve. However, the progression of the FBR to Parylene C implanted in the nerve has 
not been described yet and is mandatory to know the effect of Parylene C over long periods of time
In order to test whether Parylene C may be a suitable material for intraneural applications, test samples were 
aged, both in vitro and in vivo, and investigated chemically and mechanically. On the other hand, the cellu-
lar and molecular processes participating in the FBR to Parylene C mock devices implanted in the rat sciatic 
nerve have been characterized from 1 day up to 8 months. Finally, a comparison in the cytokine expression after 
implant has been performed with polyimide mock devices, as a standard polymer currently used in flexible neural 
interfaces23–25.
Results
Long-term stability of Parylene C substrates. The mean Young’s modulus of an unaged sample was 
measured as 3.31 GPa and thus noticeable higher than the manufacturer’s value of 2.76 GPa. A general trend of 
decreasing Young’s modulus and rising divergence of the minimum and maximum values was found (Fig. 1B). 
However, an exception was observed at month 8, thus the correlation needs to be regarded as an estimation. 
ANOVA testing revealed a statistically significant difference between the grouped samples.
The mean initial strain at tensile strength was measured as 2.64%, in good accordance with the manufacturer’s 
data. Mean initial strain at break was measured as 8.63%, which is way below the expected value. Over time a 
slight increase in the strain was observed (Fig. 1C). All mechanical properties are presented in Table 1.
The spectra of fresh, aged, explanted and intentionally oxidized Parylene C are depicted in Fig. 2. All peaks 
were in good accordance with the characteristic FT-IR peaks of Parylene C26. Parylene C has very little peaks 
outside the fingerprint region (500 cm-1 to 1450 cm-1). Whereas the intentionally, at low temperature, oxidized 
Figure 1. (A) Tensile testing samples, according to DIN EN ISO 527-3. (B) Young’s modulus of aged Parylene 
C samples as box plots. Depiction of 10 samples per measurement set. Maximum length of whiskers is 1.5 times 
the interquartile range (IQR). ANOVA: F(6,60) = 3.04, p-value = 0.01. Significance (Tukey): *p < 0.05. (C) 
Strain at tensile strength of aged Parylene C samples as box plots. Depiction of 10 samples per measurement 
set. Maximum length of whiskers is 1.5 times IQR ANOVA: F(6,60) = 7.39, p-value = 6.1*10−6. Significance 
(Tukey): *p < 0.05, **p < 0.001.
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sample exhibited an expected oxidation peak, all other samples did not possess any new peaks, correlating to the 
change or addition of functional groups or degradation.
Nerve response and capsule formation. Electrophysiological tests showed no differences in gastrocne-
mius CMAP amplitude and latency between implanted and sham animals. Moreover, the results of the Von Frey 
test showed no changes in pain thresholds, and the SFI values remained within normal locomotor values for the 
implanted and the sham groups (Supplementary Fig. 1A–D).
Light microscopy observations showed no alterations in the fascicular architecture compared to control 
nerves, and the total number of myelinated fibres did not show significant differences in both implanted and 
sham nerves at the different time-points analysed, from 1 day to 32 weeks (Supplementary Fig. 1E–G). Detailed 
evaluation of the tissue deposition around the implanted devices was performed under light and transmission 
electron microscopy. In sham-operated animals, no scar tissue could be identified at any time point (Fig. 3A). In 
contrast, clear tissue deposition was observed around the Parylene C device implant (Fig. 3B). The thickness of 
the tissue capsule increased up to 30 µm during the first two weeks of implant, followed by stabilization and pos-
sible compaction at 4 weeks. However, the tissue deposition showed a later increase from 8 to 16 weeks, when it 
achieved a maximum of 50 µm thickness, and then appeared stabilized at 32 weeks post implant (Fig. 3C).
0 mon. 2 mon. 4 mon. 6 mon. 8 mon. 10 mon. 12 mon.
Young’s modulus E in GPa 3.31 3.09 2.93 3.04 3.04 3.03 2.90
Max 3.61 3.41 3.27 3.41 3.18 3.43 3.46
Min 3.13 2.71 2.64 2.72 2.89 2.63 2.31
Elongation at tensile str. εy in % 2.6 2.9 3.0 2.7 3.1 3.1 3.0
Max 2.8 3.0 3.3 2.9 3.7 3.6 3.4
Min 2.3 2.8 2.6 2.2 2.7 2.8 2.6
Table 1. Mechanical properties of aged Parylene C. Samples were stored in PBS up to 12 months (mon.). 
Evaluation over n = 10 samples.
Figure 2. FTIR spectra of fresh, aged, explanted and intentionally oxidized Parylene C samples. The absorption 
is presented in arbitrary units. Only oxidized Parylene C exhibits an additional peak.
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Early changes in the vicinity of the implants were observed by TEM during the first days following the implan-
tation. After one day, axons were still in close contact with the device and no foreign cells were seen near the 
device (Fig. 4A). However, by day 2, amoeboid cells appeared in the space between axons and the device embed-
ded in a loose and disorganized matrix (Fig. 4B). At 2 weeks, the capsule surrounding the Parylene C implant 
appeared full of more organized amoeboid cells (Fig. 4C). There were some figures of axonal degeneration near 
the implant and macrophagic cells engulfing the myelin debris. After 8 weeks, spindle-shaped cells started to 
appear at the edge of the capsule surrounded by collagen fibrils (Fig. 4D,I). At this time, two zones could be differ-
entiated in the capsule: an inner area with compacted amoeboid cells in contact with the device, and an outer area 
where spindle-shape cells were near the axons. This pattern remained with time; by 16 weeks post-implant, the 
inner area remained similar, and the outer zone appeared thicker and with more spindle-shaped cells embedded 
in a dense collagen matrix (Fig. 4E,J,K). After 8 months post-implant, the tissue around the device appeared as a 
compact and organized matrix with spindle-shaped cells and some FBGCs in the inner zone (Fig. 4F,L).
Cellular characterization of the FBR. Macrophage infiltration in the nerve was analyzed by Iba1 labe-
ling as a measure of the inflammatory response. In the sham implanted tibial nerves, the number of Iba1+ cells 
increased during the first days after implant but resolved to near normal levels at 2 weeks. In contrast, in Parylene 
C implanted nerves the number of iba1+ cells persisted at a high level from 4 days to 4 weeks after implant 
(Fig. 5). Besides, resolution of the inflammatory infiltration started at 8 weeks, and it was not complete even at 
32 weeks. Thus, there was an early inflammatory reaction from the surgery, but the device implanted caused a 
persistent infiltration of macrophages and inflammatory cells in the nerve with delayed resolution.
Figure 3. Progression of tissue capsule formation around the Parylene C device implanted in the nerve. 
Representative light microscopy images of (A) sham nerves after 1 day and 2 weeks in which no tissue 
deposition can be appreciated, (B) Implanted nerves with progressive tissue capsule around the device at 1 day, 
2, 8 and 32 weeks. (C) Increase in tissue capsule thickness along time. Scale bar = 50 µm. *p < 0.05 vs 2w. 
#p < 0.05 vs 16w.
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To determine the cellular mediators of the FBR to Parylene C devices, we used immunolabeling of the cap-
sule tissue around the implant. Iba1 positive cells rapidly surrounded and started to form the capsule around 
the Parylene C device (Fig. 6). From 4 days to 4 weeks post-implant only Iba1 positive amoeboid cells were 
found around and in direct contact with the device. From 8 to 16 weeks post-implant, iba1+ cells became more 
organized and flattened. On the other hand, CD90+ fibroblast cells started to appear at the edge of the capsule 
Figure 4. Detailed evaluation of tissue capsule by TEM. (A–F) Representative images of the tissue capsule at 
1 and 2 days, 2, 8, 16 and 32 weeks postimplant. Scale bar = 10 µm. At (A) 1 day, (B) 2 days and (C) 2 weeks 
only amoeboid cells (arrows) were seen in the vicinity of the device. From (D) week 8 two different zones can 
be distinguished in the capsule (dotted line), with spindle-shaped cells localized at the periphery of the capsule 
(arrowheads). After (E) 16 and (F) 32 weeks post-implant, the capsule was mainly formed by spindle-shaped 
cells and collagen fibers (insets, G–L). Insets show the progressive change from (G–H) amoeboid cells at early 
time points to (I–L) spindle-shaped cells, together with an increase in (K–L) collagen deposition from 8 weeks. 
Scale bar = 2 µm.
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at 8 weeks. By week 32 post-implant, only CD90 positive cells were observed in the capsule around the implant, 
without presence of Iba1+ cells (Fig. 6).
The presence of FBGC in the capsule was also analyzed as a hallmark of the FBR. These cells are the result of 
macrophage fusion when those are unable to phagocytize large devices and adopt an extracellular degradation 
strategy27. FBGC appeared soon after the implantation, and its number increased until 2 weeks, when it slightly 
decreased and remained stable (Supplementary Fig. 2). However, there were no significant variations in its size at 
any studied time point.
Molecular environment of the FBR. To further characterize the immune response to devices implanted 
in the peripheral nerve, cytokines and TGFβ levels were quantified using Luminex technology from 6 hours to 8 
weeks post-implantation. This analysis was also made for polyimide devices for comparison.
On the one hand, the analysis showed an increase for most of the studied factors at 6 hours and 1 day after 
surgery in the implanted and sham nerves in comparison to intact nerves, which was recovered to control val-
ues from 4 days onwards (Supplementary Fig. S3). On the other hand, there were no differences in the levels of 
the main pro-inflammatory, anti-inflammatory or tissue-remodelling factors between Parylene C or polyimide 
implanted nerves and the sham animals (Fig. 7 and Supplementary Fig. S4). However, an increase in the levels 
of CCL2 and CCL3 was observed for both materials in comparison to sham animals at chronic time points. 
Moreover, there were not any different factor at any time point between the responses to Parylene C or polyimide 
devices (Fig. 7 and Supplementary Fig. S4C). Some interleukins, such as IL1a, IL1b, IL17A, and IL13, showed 
very high values at 6 hours and 1 day after implant. At chronic time points, there were no apparent differences 
between materials in any of the studied cytokines. MIP2/CXCL2 was the only one to show different levels between 
Parylene C and polyimide from 4 days to 8 weeks, although they were no statistically significant.
Discussion
After the implantation of any device in the body, several cellular and molecular changes such as protein adsorp-
tion, cellular infiltration, tissue deposition and encapsulation of the implanted device occur7,8. In the case of 
neural interfaces, they need direct interaction with neural fibers to stimulate or record from them, and the encap-
sulation due to the FBR induces a gradual decline of neural electrodes function16,18. Novel strategies such as 
Figure 5. Iba1 labeling of infiltrating macrophages in the tibial nerve. Representative images of (A) implanted 
and (B) sham nerves at different time-points. Scale bar = 100 µm. (C) Number of iba1 positive cells in the whole 
tibial nerve along time. *p < 0.05 vs sham animals. #p < 0.05 vs 2w implanted.
www.nature.com/scientificreports/
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Figure 6. Cellular composition of the capsule. Representative confocal microscopy images labeling against Iba1 
and CD90 markers. Only iba1+ macrophages were observed from (A) 1 day to (E) 4 weeks post-implant. From 
(E) 8 to (F) 16 weeks, CD90+ fibroblasts were located in the periphery of the capsule and by (G) week 32w, 
CD90+ fibroblasts occupied most of the area of the capsule. Iba1 in red, CD90 in green, DAPI in blue. Scale 
bar = 5 µm.
Figure 7. Cytokines levels obtained by multiplex analysis. Heatmaps showing the changes in several proteins 
at different time points in (A) Parylene C and (B) polyimide implanted nerves versus sham nerves. Results are 
expressed as the mean of the ratio between each group and sham values. (C) Heatmap representing the changes 
in Parylene C implanted nerves with respect to polyimide implanted nerves. Results expressed as the mean of 
the ratio between Parylene C and polyimide values. Crossed out squares mean no protein detected.
www.nature.com/scientificreports/
8SCIENTIFIC REPORTS |  (2018) 8:5965  | DOI:10.1038/s41598-018-24502-z
the investigation of different polymers and coatings28–30 have been developed to overcome this problem. In this 
regard, Parylene C has been used as an insulator13,31 and as a substrate16,32–34 in neural applications35. Here we 
have focused on the characterization of the FBR to Parylene C devices to determine its suitability for peripheral 
nerve interfaces.
The mechanical parameters of Parylene C deviated from the manufacturer’s data. Whereas Young’s modulus 
was higher, the strain at tensile strength was in good accordance with the expected value. A possible explanation 
for the deviation might be in the low deposition pressure of 20 mTorr used in sample fabrication, in contrast to 
the recommended pressure of 60 mTorr by the supplier. As discussed by Hassler et al. the general conformity of 
Parylene C is dependent from the actual deposition parameters31. Concerning the elongation, Song et al. could 
prove a strong dependency from deposition pressures between 25 and 45 mTorr36.
Ageing and in vivo experiments had no apparent chemical effect on Parylene C, which would have been 
observable by an oxidation peak or missing bands in the FTIR spectra. However, an influence on the mechanical 
properties was observed for aged samples. Young’s modulus slightly decreased over time, whereas the strain at 
tensile strength slightly increased. For a repetition of the in vivo studies, another standard with smaller tensile 
testing samples would be recommended.
Regarding the functional properties of the nerves with Parylene C implanted devices, there were no alterations 
in the nerve conduction, nociception, and locomotion. Moreover, no changes in the nerve architecture and the 
total number of myelinated axons were found due to surgery or the device implanted. Taking into account that 
the model used is a longitudinal device, these results are in agreement with previous studies with thin film longi-
tudinal intrafascicular electrodes25. Besides, these results confirm the biocompatible characteristics of Parylene C 
as there were no harmful effects on nerve function19,37.
Several studies, mainly using subcutaneous and intraperitoneal implants7,8,27 have shown that the FBR has a 
first inflammatory phase followed by a tissue remodelling phase, and a similar pattern has been observed for the 
FBR in peripheral nerve implant models38–41. First, macrophages rapidly infiltrate the nerve after the implantation 
and start to surround the device after 1 day. These infiltrating cells generate a cellular capsule that enlarges until 2 
weeks, coinciding with the peak of the inflammatory reaction. In parylene C implanted nerves, nerve inflamma-
tion is resolved by 8 weeks, but the thickness of the capsule increases up to 16 weeks with a change in its cellular 
composition and fibroblasts appearing in the edge of the tissue capsule by week 8. However, although the response 
to intraneural implants of Parylene C is similar to that recently described for polyimide implants with the same 
physical shape and dimensions39, a thicker tissue deposition has been found. Moreover, macrophages remained 
for a longer time in the inner zone of the capsule and more fibroblasts appeared around Parylene C implants in 
comparison with polyimide devices. Thus, the specificities and time evolution of the FBR should be studied for 
each material used and the tissue in which the device is implanted11.
In light of these results, it seems that Parylene C is stimulating a different pattern of FBR than polyimide 
devices. The general pattern of the FBR for non-degradable implants is a switch from a pro-inflammatory to an 
anti-inflammatory and tissue deposition environment. A direct relationship seems to occur between these two 
phases42,43. However, in the case of Parylene C devices, while the inflammatory reaction decreased, evidenced 
by the disappearance of Iba1 positive cells in the whole nerve after 8 weeks of the implant, the tissue deposition 
continued increasing, and macrophages remained in the tissue capsule to the implant.
Molecular analyses were performed to clarify these particular differences in the FBR between the two materi-
als. However, no differences in the expression of several inflammation-related cytokines were observed between 
Parylene C and polyimide responses at any time point. This could be explained by the fact that highest levels of 
cytokines are generally found within the first hours or days after injury44–46. In our model, the injury due to the 
implantation is resolved by about 2 weeks, and by then, the levels of cytokines are already decreased. By week 8, 
inflammation of the nerve is almost resolved, cytokines levels have decreased, and the contribution of each mate-
rial to cytokines production is not detected in the whole homogenized nerve. Hence, further analyses are needed 
to evaluate the macrophage activation in the local area surrounding the Parylene C implants. Even though, our 
results point at CCL3 and CCL5 as potential targets to reduce the tissue deposition around implanted devices. It 
has been shown that CCL3/MIP1a and CCL5/RANTES recruit polymorphonuclear cells and macrophages44,45,47, 
thus increasing the inflammatory phase of the FBR. On the other hand, CXCL2 levels are also increased in 
Parylene C in comparison to polyimide implanted nerves at chronic time points, although no significantly.
Differences in FBR can have their origin in the different chemical structure of polyimide and Parylene C. 
While the aromatic rings in the polyimide are in stable configurations, Parylene C is known to have non-saturated 
radicals at the carbon atoms that might result in different surface potentials (Zeta-potential) that influence inter-
action with proteins at the material-tissue interface48,49. Differences in polymer surface would also explain these 
results. Jones and co-workers showed that hydrophilic surface promotes less cellular adhesion but a higher 
cytokine production50. Although both materials show a hydrophobic behaviour with contact angles ranging from 
80 to 100°, Parylene C can be considered more hydrophilic than polyimide19,51, which could explain the higher 
matrix deposition due to a higher inflammatory environment.
In summary, the implantation of a Parylene C device mimicking a longitudinal nerve electrode does not cause 
noticeable damage to the peripheral nerve, and shows good biocompatibility. However, the generated FBR is 
stronger against Parylene C than to polyimide-based devices, that results in a thicker tissue capsule around the 
implanted device. Even its sound biocompatible and functional characteristics showed in this and other stud-
ies15,16,18,19, the increased tissue deposition in comparison to polyimide would rule Parylene C out as a neural 
substrate. Moreover, our results point out the need for specific studies for each material and each implanted tissue, 
regarding the differences that can arise after chronic implants.
www.nature.com/scientificreports/
9SCIENTIFIC REPORTS |  (2018) 8:5965  | DOI:10.1038/s41598-018-24502-z
Material and Methods
Mechanical and chemical investigation in vitro. Mechanical and chemical evaluation of aged Parylene 
C was performed with 10 µm thick samples according to DIN EN ISO 527-3 “Plastics - Determination of tensile 
properties - Part 3: Test conditions for films and sheets” (DIN EN ISO 527-3:2003-07 2003) (Fig. 1A). From the 
different possible designs, type 1B was scaled down by a factor of three, which enables tensile testing as well as 
subcutaneous in vivo implantation.
The samples were stored in PBS at 37 °C for up to 12 months in a dark environment. From each set 10 samples 
were taken out of the PBS and allowed to dry overnight. Each sample was fitted with a small piece of Kapton 
tape at the ends and clamped between the clamp jaws of a tensile tester (Z2.5, Zwicki-Line, Zwick/Roell, Ulm, 
Germany). The clamp jaws were additionally equipped with abrasive paper to provide a stronger grip on the thin 
samples. Force measurements were detected with a 50 N load cell (KAP-S, A.S.T. GmbH, Wolznach, Germany). 
After applying an initial load of 2 MPa, the clamps moved apart with a velocity of 5 mm/min. Even though it is 
common practice to measure Young’s modulus by fitting a straight line between the stress at 0.05% and 0.25% of 
strain, it was measured between 0.25% and 0.5% due to the low initial load52. Furthermore, the strain on tensile 
strength was derived from the measured stress-strain diagrams.
The aspect of possible chemical degradation was investigated by Fourier-transform infrared spectroscopy 
(FTIR). An FTIR (2000 FT-IR Scimitar Series, Varian Inc., Palo Alto, California, United States) was fitted with 
an attenuated total reflectance (ATR) unit (MKII Golden Gate, Specac Ltd., Orpington, Kent, United Kingdom) 
and flushed with nitrogen. Measurements were performed against a nitrogen atmosphere, constantly flushing for 
15 minutes. Additionally, fresh Parylene C samples were heated to 150 °C for three minutes under normal atmos-
phere, to act as a slightly degraded sample.
Animals and surgical procedures. Female Sprague-Dawley rats (250–300 g, n = 6–8/group) were anaes-
thetised using ketamine-xylazine (90/10 mg/kg i.p.). The sciatic nerve was surgically exposed at the midthigh and 
Parylene C or polyimide double devices (20 mm long, 200 µm wide and 10 µm thick), similar to tfLIFE electrodes, 
were longitudinally implanted in the tibial branch as before25,53. A group of sham animals underwent the same 
procedure but leaving no device inside the nerve.
Animals were housed at 22 ± 2 °C under a 12:12 h light cycle with food and water ad libitum. All animal exper-
iments were approved by the Ethical Committee of the Universitat Autònoma de Barcelona in accordance with 
the European Communities Council Directive 2010/63/EU.
At 6 hours, 1, 2, 4 days, 2, 4, 8, 16, and 32 weeks post-implant, animals were deeply anesthetized with an over-
dose of pentobarbital and transcardially perfused with 4% paraformaldehyde in PBS or saline. The sciatic nerve 
including the device was harvested for histological or molecular analysis.
Additionally, a set of 10-µm-thick samples according to DIN EN ISO 527–3 were implanted subcutaneously 
in the back of another group of rats to evaluate the chemical and mechanical properties of aged Parylene C after 1 
year of implant. Animals dorsum was shaved and disinfected with 70% alcohol and povidone iodine. Afterwards, 
3 incisions were done on the back, with a distance of 2 cm between incisions and the skin surrounding the inci-
sions was separated from the dorsal subcutaneous tissue in order to prepare three implant pockets per animal. 
The pieces were placed and fixed inside each pocket.
The polyimide bulk material was fabricated from the liquid precursor U-varnish-S by UBE Industries (Tokio, 
Japan). In the liquid state, it can be spin-coated and, after evaporation of the solvent, cured at 350 °C54. The 
Parylene C bulk material was deposited with the Gorham process from the dimer di-para-xylylene C within a 
parylene coater (both from SCS Speciality Coating Systems Inc., USA)16.
Functional evaluation. To evaluate functional properties of the implanted nerves, nerve conduction, alge-
simetry and locomotion tests were performed at different time points after implant. Nerve conduction test was 
performed by stimulating the sciatic nerve proximally with single electrical pulses and recording the compound 
muscle action potentials (CMAPs) of gastrocnemius medialis (GM) muscle as previously described4,25. Pain 
threshold to mechanical stimuli was assessed by means of an electronic Von Frey algesimeter (Bioseb, Chaville, 
France). The hindpaw plantar surface was stimulated by applying a non-noxious pointed probe, slowly increasing 
the pressure until the rat withdrew the paw in response to the stimulus55. The walking track test was performed to 
assess locomotor function after the implant. The plantar surface of the hind paws was painted with black ink, and 
the rat was left to walk along a corridor freely. The print length, the distance between the 1st and the 5th toes and 
between the 2nd and the 4th toes were measured to calculate the Sciatic Functional Index (SFI)56.
Morphological evaluation. To evaluate the microstructure of implanted nerves and the myelinated axons, a 
segment of the tibial nerve was sectioned in semithin sections (0.5 µm-thick) and stained with toluidine blue after 
epon resin embedding. To estimate the number of myelinated fibers in the tibial nerve, sections were examined by 
light microscopy and axons were counted in images at 100×, chosen by systematic selection and representing at 
least the 30% of the nerve cross-section area. The whole area of the tibial nerve was measured in 4× images. Using 
the same sections, the thickness of the tissue capsule around the devices implanted was measured as the distance 
between each side of the device and the closest myelinated axon using ImageJ software.
Transmission electron microscopy (TEM) was performed to analyse the tissue and the collagen deposition 
around Parylene C implanted devices. Ultrathin sections (70 nm) were cut, mounted on formvar 200 mesh copper 
grids and contrasted with uranyl acetate/lead citrate. Images of the area with the device were taken using a TEM 
microscope (JEM 1400) to evaluate the encapsulating tissue at different time points.
Immunohistochemistry. Another nerve segment containing the device implanted was serially cut (15 µm) 
with a cryostat. Slides were incubated overnight at 4 °C with primary antibodies anti-iba1 (Wako, 1:500) for 
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macrophages and anti-CD90 (BD Pharmingen, 1:150) for fibroblasts. Slides were then washed and incubated 
with secondary antibodies for 1 h at room temperature, and mounted with mowiol containing DAPI (0,1 μg/ml).
To quantify the number of infiltrating Iba1+ macrophages, images of the whole tibial nerve were taken with 
an epifluorescence microscope BX51 (Olympus) attached to a DP73 digital camera (Olympus) and equally treated 
to adjust brightness and contrast. The background was subtracted and a threshold of detection and binarization 
was applied using ImageJ software. Iba1 positive cells in the whole tibial nerve, excluding the implanted device 
and tissue surrounding, were counted using the plugin “Analyze Particles” of ImageJ39.
Haematoxylin-eosin staining. To determine the amount of foreign body giant cells (FBGCs) around the 
implant, cryostat sections were immersed in hematoxylin Harris solution for 7 min and washed in water fol-
lowed by 1% HCl in ethanol solution for 20 sec. Sections were washed again with water and stained with Eosin 
Y for 5 min, dehydrated with series of graded ethanol rinses and mounted with DPX. The number of FBGC 
was counted under the microscope in each stained section and expressed as FBGC per mm of implant width. 
Moreover, pictures of every FBGC were taken, and the diameter was measured with ImageJ.
Cytokine protein expression. Other animals were transcardially perfused with sterile saline, and 1 cen-
timetre of the sciatic nerve including the implanted device was taken after 6 hours, 1 and 4 days, 2 and 8 weeks 
post-implant, snap-frozen with liquid nitrogen and kept at −80 °C. Sciatic nerves were homogenized with HEPES 
buffer and the protein concentration was determined using Pierce BCA assay kit. To ensure equal amounts of 
protein, all samples were diluted with HEPES to 4 µg/µl. Protein levels of a panel of cytokines (EGF, CCL11, 
Fraktalkine/CX3CL1, GCSF, GMCSF, CXCL1, IFNγ, IL1α, IL1β, IL2, IL4, IL5, IL6, IL10, IL12, IL13, IL17A, 
IL18, IP10/CXCL10, Leptin, LIX/CXCL6, MCP1/CCL2, MIP1α/CCL3, MIP2/CXCL2, RANTES/CCL5, TNFα, 
VEGF-A) and TGFβ (TGFβ1, TGFβ2, TGFβ3) were analyzed using the Milliplex map Rat Cytokine/Chemokine 
magnetic bead panel (RECYMAG65PMX27BK, Merck Millipore) and the Milliplex map TGFβ magnetic bead 3 
Plex Kit (TGFBMAG-64K-03, Merck Millipore). Proteins with levels lower than detection limit are not shown.
Statistical analysis. Reported values show the mean ± SEM. Differences between groups or times were 
analyzed by one or two-way ANOVA followed by Bonferroni post hoc tests (GraphPad Prism) for the animal 
experiments. Post-hoc Tukey’s range test was conducted for the mechanical experiments if the ANOVA showed 
statistical significance to rule out which groups were statistically different. Statistical significance was considered 
at p < 0.05. For protein levels, results are expressed as the ratio with intact, sham or polyimide values in heatmaps.
Data availability. All data generated and analyzed during the current study are available from the corre-
sponding author on reasonable request.
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